Alexion Pharmaceuticals
ALXN
#631
Rank
โ‚น3.870 T
Marketcap
โ‚น17,510
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Alexion Pharmaceuticals (ALXN)

Revenue in 2021 (TTM): โ‚น462.63 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current revenue is โ‚น600.63 Billion. In 2020 the company made a revenue of โ‚น582.29 Billion an increase over the revenue in the year 2019 that were of โ‚น478.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexion Pharmaceuticals from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น462.63 B-20.55%
2020โ‚น582.29 B21.63%
2019โ‚น478.76 B20.82%
2018โ‚น396.26 B16.36%
2017โ‚น340.55 B15.17%
2016โ‚น295.70 B18.42%
2015โ‚น249.69 B16.51%
2014โ‚น214.31 B43.99%
2013โ‚น148.84 B36.79%
2012โ‚น108.81 B44.76%
2011โ‚น75.16 B44.82%
2010โ‚น51.90 B39.85%
2009โ‚น37.11 B49.29%
2008โ‚น24.85 B259.66%
2007โ‚น6.91 B4523.88%
2006โ‚น0.14 B13.14%
2005โ‚น0.13 B-70.12%
2004โ‚น0.44 B557.49%
2003โ‚น67.25 M-85.98%
2002โ‚น0.47 B-50.6%
2001โ‚น0.97 B